The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 16, 2019
Filed:
Apr. 13, 2012
Applicants:
Jaime Modiano, Roseville, MN (US);
Donald Bellgrau, Highlands Ranch, CO (US);
Richard C. Duke, Denver, CO (US);
Inventors:
Jaime Modiano, Roseville, MN (US);
Donald Bellgrau, Highlands Ranch, CO (US);
Richard C. Duke, Denver, CO (US);
Assignee:
ApopLogic Pharmaceuticals, Inc., Aurora, CO (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A01N 63/00 (2006.01); A61K 48/00 (2006.01); G01N 33/574 (2006.01); C12Q 1/6886 (2018.01); C12Q 1/6888 (2018.01); G01N 33/68 (2006.01); A61K 38/17 (2006.01); A61K 38/19 (2006.01);
U.S. Cl.
CPC ...
G01N 33/57492 (2013.01); A61K 38/177 (2013.01); A61K 38/191 (2013.01); C12Q 1/6886 (2013.01); C12Q 1/6888 (2013.01); G01N 33/57407 (2013.01); G01N 33/6863 (2013.01); C12Q 2600/106 (2013.01); G01N 2333/7151 (2013.01); G01N 2800/52 (2013.01);
Abstract
The invention provides methods for using expression levels of Fas to select individuals or subpopulation of individuals who can benefit from an anti-cancer therapy and for assessing whether an individual suspected of having or developing cancerous tumors will beneficially respond to an anticancer therapy. The invention additionally provides methods of treatment for individuals selected as likely to benefit from anti-cancer therapy based on Fas expression levels.